Kestra Medical Technologies (NASDAQ:KMTS) Issues Quarterly Earnings Results, Misses Expectations By $1.55 EPS

Kestra Medical Technologies (NASDAQ:KMTS - Get Free Report) announced its earnings results on Tuesday. The company reported ($2.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.54) by ($1.55), Zacks reports. The firm had revenue of $17.23 million during the quarter, compared to the consensus estimate of $15.72 million. Kestra Medical Technologies updated its FY 2026 guidance to EPS.

Kestra Medical Technologies Price Performance

KMTS stock traded down $2.08 during mid-day trading on Wednesday, hitting $14.21. The stock had a trading volume of 209,823 shares, compared to its average volume of 257,872. Kestra Medical Technologies has a 1-year low of $13.25 and a 1-year high of $26.15. The business's fifty day moving average price is $19.27.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on KMTS shares. Wells Fargo & Company started coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They set an "overweight" rating and a $28.00 target price on the stock. Bank of America assumed coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They set a "buy" rating and a $30.00 price target on the stock. Wolfe Research started coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They set an "outperform" rating and a $29.00 price objective for the company. Stifel Nicolaus assumed coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They set a "buy" rating and a $28.00 target price on the stock. Finally, Piper Sandler started coverage on shares of Kestra Medical Technologies in a research report on Monday, March 31st. They issued an "overweight" rating and a $27.00 price target for the company. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, Kestra Medical Technologies has an average rating of "Moderate Buy" and an average target price of $27.50.

Hedge Funds Weigh In On Kestra Medical Technologies

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Millennium Management LLC bought a new position in Kestra Medical Technologies during the first quarter valued at approximately $11,036,000. Woodline Partners LP bought a new position in Kestra Medical Technologies during the first quarter valued at about $2,510,000. Finally, Jane Street Group LLC acquired a new stake in shares of Kestra Medical Technologies in the first quarter worth about $756,000.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.